Shah BB - Search Results

1

A randomized trial of varenicline (chantix) for the treatment of spinocerebellar ataxia type 3.

Connolly BS, Prashanth LK, Shah BB, Marras C, Lang AE. Connolly BS, et al. Among authors: shah bb. Neurology. 2012 Nov 27;79(22):2218. doi: 10.1212/WNL.0b013e318278a059. Neurology. 2012. PMID: 23183282 No abstract available.

2

Caffeine for treatment of Parkinson disease: a randomized controlled trial.

Postuma RB, Lang AE, Munhoz RP, Charland K, Pelletier A, Moscovich M, Filla L, Zanatta D, Rios Romenets S, Altman R, Chuang R, Shah B. Postuma RB, et al. Neurology. 2012 Aug 14;79(7):651-8. doi: 10.1212/WNL.0b013e318263570d. Epub 2012 Aug 1. Neurology. 2012. PMID: 22855866 Free PMC article. Clinical Trial.

3

Clinical features of dopamine agonist withdrawal syndrome in a movement disorders clinic.

Pondal M, Marras C, Miyasaki J, Moro E, Armstrong MJ, Strafella AP, Shah BB, Fox S, Prashanth LK, Phielipp N, Lang AE. Pondal M, et al. Among authors: shah bb. J Neurol Neurosurg Psychiatry. 2013 Feb;84(2):130-5. doi: 10.1136/jnnp-2012-302684. Epub 2012 Aug 29. J Neurol Neurosurg Psychiatry. 2013. PMID: 22933817

4

A case of neurosyphilis presenting with myoclonus, cerebellar ataxia, and speech disturbance.

Shah BB, Lang AE. Shah BB, et al. Mov Disord. 2012 May;27(6):794. doi: 10.1002/mds.24952. Epub 2012 Mar 7. Mov Disord. 2012. PMID: 22407549 No abstract available.

5

Acquired neurosyphilis presenting as movement disorders.

Shah BB, Lang AE. Shah BB, et al. Mov Disord. 2012 May;27(6):690-5. doi: 10.1002/mds.24950. Epub 2012 Mar 12. Mov Disord. 2012. PMID: 22410849 Review.

6

Expanding the phenomenology of benign hereditary chorea: evolution from chorea to myoclonus and dystonia.

Armstrong MJ, Shah BB, Chen R, Angel MJ, Lang AE. Armstrong MJ, et al. Among authors: shah bb. Mov Disord. 2011 Oct;26(12):2296-7. doi: 10.1002/mds.23822. Epub 2011 Jun 28. Mov Disord. 2011. PMID: 21714005 No abstract available.

7

Characterization of Movement Disorder Phenomenology in Genetically Proven, Familial Frontotemporal Lobar Degeneration: A Systematic Review and Meta-Analysis.

Gasca-Salas C, Masellis M, Khoo E, Shah BB, Fisman D, Lang AE, Kleiner-Fisman G. Gasca-Salas C, et al. Among authors: shah bb. PLoS One. 2016 Apr 21;11(4):e0153852. doi: 10.1371/journal.pone.0153852. eCollection 2016. PLoS One. 2016. PMID: 27100392 Free PMC article. Review.

8

Famotidine, a Histamine H₂ Receptor Antagonist, Does Not Reduce Levodopa-Induced Dyskinesia in Parkinson's Disease: A Proof-of-Concept Study.

Mestre TA, Shah BB, Connolly BS, de Aquino C, Al Dhakeel A, Walsh R, Ghate T, Lui JP, Fox SH. Mestre TA, et al. Among authors: shah bb. Mov Disord Clin Pract. 2014 Jun 26;1(3):219-224. doi: 10.1002/mdc3.12061. eCollection 2014 Sep. Mov Disord Clin Pract. 2014. PMID: 30363717 Free PMC article.

9

Surgical treatment of dystonia.

Cury RG, Kalia SK, Shah BB, Jimenez-Shahed J, Prashanth LK, Moro E. Cury RG, et al. Among authors: shah bb. Expert Rev Neurother. 2018 Jun;18(6):477-492. doi: 10.1080/14737175.2018.1478288. Epub 2018 May 28. Expert Rev Neurother. 2018. PMID: 29781334 Review.

10

Author Correction: Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial.

Dam T, Boxer AL, Golbe LI, Höglinger GU, Morris HR, Litvan I, Lang AE, Corvol JC, Aiba I, Grundman M, Yang L, Tidemann-Miller B, Kupferman J, Harper K, Kamisoglu K, Wald MJ, Graham DL, Gedney L, O'Gorman J, Haeberlein SB; PASSPORT Study Group. Dam T, et al. Nat Med. 2023 Nov;29(11):2955-2956. doi: 10.1038/s41591-022-02076-8. Nat Med. 2023. PMID: 36253611 Free article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters